Century Therapeutics, Inc.

IPSCNASDAQHealthcare● Active

$2.12

$-0.01(-0.47%)

Market Cap$183527105

P/E Ratio—

52W High$3.04

52W Low$0.435

Avg Volume1.2M

Open$2.13

Beta1.57

Overview

Century Therapeutics, Inc.（IPSC）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · IPSC · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.21

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 18%仅显示有效交易 · 排除RSU归属82% Sell ↓

Century Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

IPSC 季度内部人买卖趋势

IPSC 内幕交易卖出 · IPSC 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

2.6M1.3M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · IPSC CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

IPSC 高管卖出股份 · IPSC 董事内幕交易 · SEC Form 4申报

显示最近 67 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 15, 2026	Pfeiffenberger Brent President and CEO · Director	Other	31,172	$2.34	$73K	3,679,786	Form 4
May 4, 2026	Carr Douglas SVP Finance & Operations	Sale	264	$2.34	$618	506,997	Form 4
Apr 1, 2026	Cowan Chad Chief Scientific Officer	Other	1,365	$2.19	$3K	1,175,680	Form 4
Mar 12, 2026	Carr Douglas SVP Finance & Operations	Sale	7,043	$2.55	$18K	507,261	Form 4
Mar 12, 2026	Russotti Gregory See Remarks	Sale	10,076	$2.55	$26K	515,427	Form 4
Mar 11, 2026	Pfeiffenberger Brent President and CEO · Director	Other	55,397	$2.73	$151K	3,710,958	Form 4
Mar 11, 2026	Cowan Chad Chief Scientific Officer	Other	1,431	$2.73	$4K	1,177,045	Form 4
Mar 9, 2026	Russotti Gregory See Remarks	Sale	479	$2.54	$1K	525,503	Form 4
Mar 6, 2026	Pfeiffenberger Brent President and CEO · Director	Other	463	$2.56	$1K	3,766,355	Form 4
Feb 13, 2026	Pfeiffenberger Brent President and CEO · Director	Other	31,172	$1.75	$55K	3,766,818	Form 4
Feb 3, 2026	Carr Douglas SVP Finance & Operations	Sale	323	$1.82	$589	514,551	Form 4
Feb 2, 2026	Pfeiffenberger Brent President and CEO · Director	Award	475,000	—	—	3,797,990	Form 4
Feb 2, 2026	Russotti Gregory See Remarks	Award	135,000	—	—	525,982	Form 4
Feb 2, 2026	Cowan Chad Chief Scientific Officer	Award	135,000	—	—	1,178,476	Form 4
Feb 2, 2026	Carr Douglas SVP Finance & Operations	Award	110,000	—	—	514,874	Form 4
Jan 2, 2026	Cowan Chad Chief Scientific Officer	Other	1,611	$0.99	$2K	1,043,476	Form 4
Dec 22, 2025	Cowan Chad Chief Scientific Officer	Purchase	58,060	$0.85	$49K	1,045,087	Form 4
Dec 12, 2025	Pfeiffenberger Brent President and CEO · Director	Purchase	52,000	$0.58	$30K	3,322,990	Form 4
Dec 10, 2025	Pfeiffenberger Brent President and CEO · Director	Other	463	$0.53	$244	3,270,990	Form 4
Dec 8, 2025	Carr Douglas SVP Finance & Operations	Sale	257	$0.53	$137	404,874	Form 4
Dec 8, 2025	Russotti Gregory See Remarks	Sale	526	$0.53	$280	390,982	Form 4
Nov 20, 2025	Cowan Chad Chief Scientific Officer	Sale	5,462	$0.50	$3K	987,027	Form 4
Nov 19, 2025	Pfeiffenberger Brent President and CEO · Director	Purchase	35,000	$0.50	$17K	3,271,453	Form 4
Nov 17, 2025	Pfeiffenberger Brent President and CEO · Director	Sale	32,456	$0.45	$15K	3,236,453	Form 4
Nov 3, 2025	Carr Douglas SVP Finance & Operations	Sale	292	$0.59	$171	405,131	Form 4

Pfeiffenberger Brent

President and CEO · Director

Other

日期

May 15

股数

31,172

均价

$2.34

总金额

$73K

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Sale

日期

May 4

股数

264

均价

$2.34

总金额

$618

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Other

日期

Apr 1

股数

1,365

均价

$2.19

总金额

$3K

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Sale

日期

Mar 12

股数

7,043

均价

$2.55

总金额

$18K

View Form 4 on SEC.gov

Russotti Gregory

See Remarks

Sale

日期

Mar 12

股数

10,076

均价

$2.55

总金额

$26K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Other

日期

Mar 11

股数

55,397

均价

$2.73

总金额

$151K

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Other

日期

Mar 11

股数

1,431

均价

$2.73

总金额

$4K

View Form 4 on SEC.gov

Russotti Gregory

See Remarks

Sale

日期

Mar 9

股数

479

均价

$2.54

总金额

$1K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Other

日期

Mar 6

股数

463

均价

$2.56

总金额

$1K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Other

日期

Feb 13

股数

31,172

均价

$1.75

总金额

$55K

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Sale

日期

Feb 3

股数

323

均价

$1.82

总金额

$589

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Award

日期

Feb 2

股数

475,000

均价

—

总金额

—

View Form 4 on SEC.gov

Russotti Gregory

See Remarks

Award

日期

Feb 2

股数

135,000

均价

—

总金额

—

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Award

日期

Feb 2

股数

135,000

均价

—

总金额

—

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Award

日期

Feb 2

股数

110,000

均价

—

总金额

—

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Other

日期

Jan 2

股数

1,611

均价

$0.99

总金额

$2K

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Purchase

日期

Dec 22

股数

58,060

均价

$0.85

总金额

$49K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Purchase

日期

Dec 12

股数

52,000

均价

$0.58

总金额

$30K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Other

日期

Dec 10

股数

463

均价

$0.53

总金额

$244

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Sale

日期

Dec 8

股数

257

均价

$0.53

总金额

$137

View Form 4 on SEC.gov

Russotti Gregory

See Remarks

Sale

日期

Dec 8

股数

526

均价

$0.53

总金额

$280

View Form 4 on SEC.gov

Cowan Chad

Chief Scientific Officer

Sale

日期

Nov 20

股数

5,462

均价

$0.50

总金额

$3K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Purchase

日期

Nov 19

股数

35,000

均价

$0.50

总金额

$17K

View Form 4 on SEC.gov

Pfeiffenberger Brent

President and CEO · Director

Sale

日期

Nov 17

股数

32,456

均价

$0.45

总金额

$15K

View Form 4 on SEC.gov

Carr Douglas

SVP Finance & Operations

Sale

日期

Nov 3

股数

292

均价

$0.59

总金额

$171

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 IPSC 内幕交易

IPSC 内幕交易

Century Therapeutics, Inc.（IPSC）内幕交易数据来源于公司内部人（包括Pfeiffenberger Brent (President and CEO · Director), Carr Douglas (SVP Finance & Operations), Cowan Chad (Chief Scientific Officer)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。IPSC内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Century Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

IPSC 内幕交易 · 5个问题

Century Therapeutics, Inc.（IPSC）的内部人包括高管和董事，如Pfeiffenberger Brent (President and CEO · Director), Carr Douglas (SVP Finance & Operations), Cowan Chad (Chief Scientific Officer)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

IPSC 董事内幕交易IPSC 内部人名单Century Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026